Comment on "Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinoma".
APA
Xu Q, Han J, Zhu J (2026). Comment on "Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinoma".. Hepatology international. https://doi.org/10.1007/s12072-026-11056-w
MLA
Xu Q, et al.. "Comment on "Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinoma".." Hepatology international, 2026.
PMID
41762385
같은 제1저자의 인용 많은 논문 (5)
- UCHL3 Promotes Triple-Negative Breast Cancer Metastatic Potential Through Enhancing Cell Migration and Invasion.
- Comparison of concurrent chemoradiotherapy followed by immunotherapy and induction chemoimmunotherapy followed by radiotherapy in unresectable stage III NSCLC: a retrospective cohort study.
- pH-responsive ZIF-8@quercetin nanoparticles induce pyroptosis for targeted gastric cancer therapy.
- Discovery of hemostatic component combination from Nelumbinis Receptaculum using dual machine learning spectrum-effect analysis.
- Targeting drug-tolerant persister cells to overcome resistance in HER2-positive gastric cancer.